Results 171 to 180 of about 57,995 (263)

Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding

Circulation: Heart Failure, 2017
K. Shah, S. Gunda, S. Emani, M. Kanwar, N. Uriel, P. Colombo, P. Uber, M. L. Sears, J. Chuang, D. Farrar, D. Brophy, G. Smallfield   +11 more
semanticscholar   +1 more source

Successful Use of Octreotide for Refractory Postural Hypotension in a Patient With Parkinson's Disease and Heart Failure With Preserved Ejection Fraction. [PDF]

Cureus
Thet K, Duric D.
europepmc   +1 more source

Complete Heart Block due to Octreotide Infusion in Patient with Cryptogenic Cirrhosis

, 2018
Yahya Kemal İçen, Örsan Deniz Urgun, Hilmi Erdem Sümbül, Mevlüt Koç   +3 more
openalex   +2 more sources

Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.

Journal of Endocrinology, 2016
A. Ibáñez-Costa, Esther Rivero-Cortés, M. Vazquez-Borrego, M. Gahete, L. Jiménez-Reina, Eva Venegas-Moreno, A. de la Riva, M. Arráez, I. González-molero, H. Schmid, Silvia Maraver-Selfa, I. Gavilán-Villarejo, J. García-Arnés, M. Japón, Alfonso Soto-Moreno, M. Gálvez, R. Luque, J. Castaño   +17 more
semanticscholar   +1 more source

Octreotide and direct/indirect lung injury. [PDF]

Res Pharm Sci
Zarei G, Pezeshki Z, Choopani S, Nematbakhsh M.   +3 more
europepmc   +1 more source

Octreotide: a clinical update.

, 1998
Rémy Meier, M M Reichert
openalex   +1 more source

Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome—over a decade of follow-up [PDF]

, 2019
Lynsey Daniels, Marian Khalili, William F. Morano, Michaela Simoncini, Beth Mapow, Andrea Leaf, Wilbur B. Bowne   +6 more
openalex   +1 more source

Chylothorax Following Thoracolumbar Corpectomy: Successful Conservative Management With Octreotide: A Case Report. [PDF]

Cureus
Mitamura S, Takahashi S, Tominaga T, Yoshida M.   +3 more
europepmc   +1 more source

Preparation and stability of poly(ethylene glycol) (PEG)ylated octreotide for application to microsphere delivery [PDF]

, 2003
Dong Hee Na, Santos B. Murty, Kang Choon Lee, B. C. Thanoo, Patrick P. DeLuca   +4 more
openalex   +1 more source

Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial.

Journal of Clinical Endocrinology and Metabolism, 2015
S. Melmed, V. Popović, M. Bidlingmaier, M. Mercado, A. J. van der Lely, N. Biermasz, M. Bolanowski, M. Coculescu, J. Schopohl, K. Rácz, B. Glaser, M. Góth, Y. Greenman, P. Trainer, E. Mezősi, I. Shimon, A. Giustina, M. Korbonits, M. Bronstein, D. Kleinberg, S. Teichman, I. Gliko-Kabir, R. Mamluk, A. Haviv, C. Strasburger   +24 more
semanticscholar   +1 more source